A 55-year-old with obesity (BMI 37 kg/m²), T2D, and hypertension asks about pharmacotherapy for weight loss. Which agent class has robust weight-loss ...

Question

A 55-year-old with obesity (BMI 37 kg/m²), T2D, and hypertension asks about pharmacotherapy for weight loss. Which agent class has robust weight-loss efficacy and CV benefits?

Accepted Answer

GLP-1 receptor agonists

Answer

Phentermine monotherapy

Answer

Orlistat

Answer

SGLT2 inhibitors for weight loss

Answer

Bupropion alone

us-abfm MCQ (SBA): Obesity Pharmacotherapy

A 55-year-old with obesity (BMI 37 kg/m²), T2D, and hypertension asks about pharmacotherapy for weight loss. Which agent class has robust weight-loss efficacy and CV benefits?